Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of Dec. 31, 2025

Portfolio Holdings for Great Point Partners

Great Point Partners holds 29 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apogee Therapeutics (APGE) 9.2 $28M 374k 75.48
Amylyx Pharmaceuticals (AMLX) 6.9 $21M 1.8M 12.08
Zura Bio Class A Ord Shs (ZURA) 6.5 $20M 3.8M 5.24
Disc Medicine (IRON) 6.4 $20M 250k 79.41
Rapt Therapeutics Com New (RAPT) 6.4 $20M 581k 33.87
Immunovant (IMVT) 6.2 $19M 750k 25.42
Soleno Therapeutics (SLNO) 6.0 $19M 400k 46.30
Vor Biopharma Com New (VOR) 5.8 $18M 1.4M 13.08
Dianthus Therapeutics (DNTH) 4.7 $14M 350k 41.21
Jade Biosciences Com New (JBIO) 4.0 $12M 806k 15.43
Kalvista Pharmaceuticals (KALV) 3.6 $11M 686k 16.15
Contineum Therapeutics Cl A (CTNM) 3.0 $9.1M 800k 11.43
Eupraxia Pharmaceuticals (EPRX) 2.9 $9.1M 1.2M 7.55
Fulcrum Therapeutics (FULC) 2.9 $9.0M 800k 11.31
Nektar Therapeutics Com New (NKTR) 2.9 $8.9M 211k 42.28
Upstream Bio (UPB) 2.6 $8.1M 300k 27.15
Neurogene (NGNE) 2.3 $7.2M 350k 20.60
Ultragenyx Pharmaceutical (RARE) 2.2 $6.9M 300k 23.00
Context Therapeutics (CNTX) 2.2 $6.9M 4.7M 1.47
Cullinan Oncology (CGEM) 2.1 $6.6M 634k 10.35
Evommune Com Shs (EVMN) 1.8 $5.6M 325k 17.12
Oruka Therapeutics (ORKA) 1.8 $5.6M 183k 30.31
Silence Therapeutics Ads (SLN) 1.6 $4.9M 808k 6.08
Unicycive Therapeutics Com New (UNCY) 1.5 $4.6M 797k 5.77
Eliem Therapeutics (CLYM) 1.3 $3.9M 980k 4.00
Sana Biotechnology (SANA) 0.9 $2.8M 700k 4.07
Pharvaris N V (PHVS) 0.7 $2.3M 83k 27.75
Avalo Therapeutics Com New (AVTX) 0.7 $2.3M 125k 18.16
Rezolute Com New (RZLT) 0.7 $2.2M 952k 2.36